GE HealthCare (NASDAQ: GEHC) director granted 3,586 restricted stock units in equity award

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

LESJAK CATHERINE A reported acquisition or exercise transactions in this Form 4 filing.

GE HealthCare Technologies Inc. director Catherine A. Lesjak received an award of 3,586 restricted stock units of GE HealthCare common stock on May 7, 2026. Each unit represents the right to receive one share of common stock at settlement and was granted at no cash cost to her.

The award will vest 100% on the earlier of GE HealthCare’s next annual meeting of stockholders or May 7, 2027. As a result of this compensation-related equity grant, Lesjak’s direct ownership reported in this filing increased to 12,702 shares of common stock, with settlement of vested units potentially deferred under the company’s Non-Employee Director Compensation and Benefits Plan.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider LESJAK CATHERINE A

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share	3,586	$0.00	--

Holdings After Transaction: Common Stock, par value $0.01 per share — 12,702 shares (Direct, null)

Footnotes (1)

Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Key Figures

Restricted stock units granted: 3,586 units Price per unit: $0.0000 per share Shares owned after transaction: 12,702 shares +1 more

4 metrics

Restricted stock units granted 3,586 units Award of RSUs on May 7, 2026

Price per unit $0.0000 per share Equity compensation, not a cash purchase

Shares owned after transaction 12,702 shares Direct ownership following the RSU award

Vesting deadline May 7, 2027 Vests earlier of next annual meeting or this date

Key Terms

restricted stock units, vesting, Non-Employee Director Compensation and Benefits Plan, settlement, +1 more

5 terms

restricted stock units financial

"Award of restricted stock units with respect to GE HealthCare Technologies Inc. common stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vesting financial

"100% will vest on the earlier of the date of GE HealthCare's next annual meeting"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Non-Employee Director Compensation and Benefits Plan financial

"settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan"

settlement financial

"Settlement of vested restricted stock units may be deferred by the director"

Settlement is the process of completing a financial transaction, like buying or selling a stock, by transferring money and ownership between parties. It ensures that both the buyer gets the asset and the seller gets paid, making the deal official. Without settlement, the transaction wouldn't be finalized or legally recognized.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

05/11/2026 - 08:12 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LESJAK CATHERINE A

(Last)

(First)

(Middle)

500 W. MONROE STREET

(Street)

CHICAGO

ILLINOIS

60661

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.01 per share	05/07/2026		A		3,586⁽¹⁾⁽²⁾	A	$0	12,702	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

2. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did GEHC director Catherine Lesjak report in this Form 4 filing?

Director Catherine A. Lesjak reported receiving 3,586 restricted stock units of GE HealthCare common stock as a compensation-related equity award. These units vest in full on the earlier of the next annual stockholders meeting or May 7, 2027, subject to the plan’s terms.

How many GEHC shares will Catherine Lesjak own after this reported grant?

After the reported grant, Catherine Lesjak’s direct ownership shown in the filing is 12,702 shares of GE HealthCare common stock. This reflects the impact of the 3,586-share restricted stock unit award, with each unit representing one share upon settlement under the plan.

What are the vesting terms of Catherine Lesjak’s 3,586 GEHC restricted stock units?

The 3,586 restricted stock units vest 100% on the earlier of GE HealthCare’s next annual meeting of stockholders or May 7, 2027. This single vesting date structure is typical for non-employee director awards, aligning compensation with service through the annual meeting cycle.

Does Catherine Lesjak pay cash for the 3,586 GEHC restricted stock units?

No cash purchase is involved for these 3,586 restricted stock units; they are a grant categorized as a “grant, award, or other acquisition.” The transaction price per share is reported as $0.0000, reflecting that this is equity compensation rather than an open-market stock purchase.

Can settlement of Catherine Lesjak’s GEHC restricted stock units be deferred?

Yes. Settlement of the vested restricted stock units may be deferred by Catherine Lesjak under GE HealthCare’s Non-Employee Director Compensation and Benefits Plan. If she elects deferral, settlement will occur based on her applicable deferral election, following that plan’s terms and timing rules.

What does each GEHC restricted stock unit granted to Catherine Lesjak represent?

Each restricted stock unit represents the right to receive one share of GE HealthCare common stock at settlement. This means when units vest and settle under the plan, Lesjak will receive an equivalent number of common shares, subject to any deferral elections she has made.